Trial intelligence / Profile preview

Cassia Alata Cream for Tinea Versicolor

NCT05730244Phase 1Recruiting

Sponsor
The University of the West Indies
Start
Mar 2025
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of Cassia alata cream in tinea versicolor, sponsored by The University of the West Indies. Primary endpoints: Lesion Clearance at 12 weeks and Fungal load at 12 weeks. Started Mar 2025; status: recruiting.

02

Drugs

Cassia alata cream
03

Conditions

tinea versicolor

Beyond the preview

Go deeper on NCT05730244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05730244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call